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Abstract
Background: Debate has been ongoing on the relative merits of olfactory ensheathing cells
(OECs) and Schwann cells as candidates for transplant-mediate repair of CNS lesions. Both glial
cells exhibit similar molecular and cellular properties and to date there has been no antigenic
marker identified that can clearly distinguish the two cell types. This inability to distinguish between
the two cells types prevents confirmation of a controversial statement that cultures of OECs are
contaminated with Schwann cells. Recently, proteomic analysis of foetal OECs and adult Schwann
cells identified an actin-binding protein, calponin, as a specific marker for OECs. However, at the
same time a recent report suggested that adult OECs do not express calponin. It was not clear if
this discrepancy was due to methodology, as cells had to be treated with proteinase K to maximize
calponin staining or developmental differences with only foetal/neonatal OECs expressing calponin.
For this reason we have examined calponin expression in the peripheral olfactory system of
embryonic and neonatal rats in vivo and from cells in vitro to assess if calponin is expressed in a
developmental manner.
Results: In this study we show that: i) proteinase K pretreatment had no effect on calponin staining
in both OECs and Schwann cells. ii) calponin immunoreactivity was not expressed by embryonic or
neonatal OECs in vitro and in vivo although connective tissue from the olfactory mucosa was strongly
positive in neonatal rats but not embryonic rats, iii) calponin expression in the olfactory mucosa
was heterogeneous, defining subpopulations of connective tissue cells iv) using functional
confrontation assays between OECs or Schwann cells with astrocytes, calponin was expressed
heterogeneously by astrocytes.
Conclusion: It is concluded that calponin is heterogeneously expressed by neonatal mucosal
connective tissue but not expressed by neonatal OECs, embryonic OECs, and neonatal Schwann
cells. Furthermore, we propose that calponin is not a specific marker for OECs generated from any
developmental age.
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Background
Olfactory ensheathing cells (OECs) are the glial cells of
the primary olfactory system [1]. The olfactory system is
comprised of both PNS and CNS tissue and known for its
ability to support neurogenesis throughout life [2,3]. It is
believed that the role of OECs in the olfactory system is to
direct the newly generated axons to their correct position
in the CNS environment of the olfactory bulb [2]. OECs
have become cells of interest due to their potential as can-
didates for transplant-mediated repair of CNS patholo-
gies, such as spinal cord injury and multiple sclerosis [4-
7]. Several studies have demonstrated that transplanted
OECs can in the right environment, myelinate experimen-
tally created demyelinated axons [8-10]. However, it has
been suggested that myelination seen after transplanta-
tion of OECs is due to contaminating Schwann cells [11]
or by host Schwann cells invading the lesion site [12-14].
It has been extremely difficult to confirm if OECs can
indeed myelinate axons in vivo due to the inability to dis-
tinguish OECs from Schwann cells using cell markers.
This is because they share many characteristics in com-
mon including antigenic and morphological phenotype
[15]. Even more striking is the similarity in their myelinat-
ing phenotype after transplantation into a CNS lesion
where the myelin formed is typical of PNS type myelin
[8,9]. Furthermore the transcriptional regulation of these
cells during myelination is very similar [16]. However,
although these cells share many antigenic characteristics,
they do not have identical biological properties. For exam-
ple, this is seen in the different way they interact with
astrocytes either in vitro [17] using "confrontation assays"
or after transplantation in vivo [17-19]. In these confron-
tation assays Schwann cells form a boundary with astro-
cytes and induce characteristics of the stress response.
These include an increase in astrocytic size and GFAP
expression levels. OECs do not form this cellular bound-
ary with astrocytes nor induce this stress response in astro-
cytes [17,20]. Recent data suggest that Schwann cells
secrete a different heparin sulphate proteoglycan profile
to OECs and it is this factor(s) that mediates this astrocytic
response [21]. These studies indicate that OECs may be
more favorable than Schwann cells in transplant-medi-
ated repair strategies. However, it is the lack of a specific
OEC or Schwann cell marker that has lead to problems in
identifying the cells after transplantation and has caused
discrepancy in deciding which glial cell is optimal for pro-
moting CNS repair [5,22,23].
Recently, proteomic analysis of foetal OECs and adult
Schwann cells has identified calponin, an actin-binding
protein, as a specific marker for OECs [24]. This has led to
some conflicting reports regarding the expression of cal-
ponin in the adult peripheral olfactory system [11,25]. In
the study from Boyd et al., [24] it was suggested that OECs
were the only glial cell to express calponin. In a later study
by Ibanez et al., [25] it was demonstrated a lack of cal-
ponin expression in cultured OECs and in vivo within the
adult rat peripheral system. However, it was not clear if
this discrepancy was due to methodology in calponin
staining as it has been reported that cells had to be treated
with proteinase K to maximize staining [11]. Discrepancy
could also be due to the different developmental age of
rats used in both studies. In our study we show that in the
presence and absence of proteinase K pretreatment punc-
tate, nuclear calponin immunoreactivity could be
detected in both neonatal OECs and neonatal Schwann
cells suggesting non-specific attachment of the secondary
antibody in both cell types. Interestingly, using confronta-
tion assays, which have been the only way to identify dif-
ferences between OECs and Schwann cells in vitro, we
observed intense, fibrillar calponin immunoreactivity
associated only with astrocytes. This intense staining was
similar to that seen for fibroblasts. Calponin immunore-
activity was also detected in astrocytes generated from P1
neurosphere cultures. As demonstrated for in vivo immu-
nohistochemistry of the rat adult peripheral olfactory sys-
tem, calponin immunoreactivity was not observed in
neonatal OECs but heterogeneously colocalised with
markers of connective tissue in the lamina propria (LP)
defining discrete areas. Furthermore embryonic tissue was
generally devoid of any calponin staining suggesting
developmental changes in expression of calponin in con-
nective tissue in the olfactory system. These data suggest
that the actin-binding protein calponin may be a marker
for subpopulations of olfactory mucosa connective tissue
cells but is not a specific marker for embryonic or neona-
tal OECs.
Results
Neonatal OECs do not express calponin in the olfactory 
mucosa in vivo
The schematic in Figure 1 illustrates the histology of the
olfactory mucosa (OM) and the cellular composition of
the olfactory epithelium (OE) and lamina propria (LP).
Olfactory receptor neurons (ORNs) extend their axons
from the OE to the LP where they coexist with the OECs
and the supportive connective tissue. Within this tissue
may also be Schwann cells ensheathing nerves innervating
blood vessels. In Figure 1A it can be seen that the calponin
immunoreactivity was only detected in the LP of neonatal
OM. Olfactory receptor nerves were intensively inmuno-
reactive for the neuronal marker TUJ1, and were sur-
rounded by cells immunoreactive for calponin (Figure 1A,
B). No colabelling was detected between calponin and
TUJ1, with calponin positive cells and their nuclei clearly
distinguishable from the nerves (Figure 1B). Since OECs
are known to typically surround ORN axons, double
immunofluorescence for calponin and the OEC markers
S100 and p75NTR was performed in the neonatal tissueBMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
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(Figure 1C–F). As expected, S100 and p75NTR positive
OECs were located just underneath the basal layer of the
OE (Figure 1D, arrow) and surrounding the nerves (Figure
1E, F, asterisk). Calponin immunoreactivity was located
close to the S100 and p75NTR positive OECs but no colo-
calisation was observed with either OEC markers
(Figure1C–F). Even though Schwann cells (identified by
the same markers as OECs) may be present in the olfac-
tory mucosa, we did not observe any cells immunoreac-
tive for both p75NTR  and calponin indicating lack of
calponin positive OECs or Schwann cells. This staining
was specific as control reactions lacking the primary anti-
body did not result in any immunoreactivity. The absence
or presence of proteinase K also has no effect on the pat-
tern of immunoreactivity.
Calponin is expressed by cells of the neonatal connective 
tissue in the lamina propria in vivo
To identify the cells that express calponin in the LP from
neonatal rats, we carried out double immunofluorescence
with antibodies to calponin together with markers of con-
nective tissue namely fibronectin (Fn) and alpha smooth
muscle actin (α-SMA). Connective tissue cells immunore-
active for α-SMA were mainly located in the central region
of the LP and associated with the olfactory nerves (Figure
2A as indicated by dashed lines). Double staining for α-
OECs in the neonatal olfactory system in vivo do not express calponin Figure 1
OECs in the neonatal olfactory system in vivo do not express calponin. The schematic in Figure 1 illustrates the his-
tology of the olfactory mucosa (OM). The OM can be divided into two parts, the olfactory epithelium (OE) and the lamina pro-
pria (LP). The OE contains mature and immature olfactory receptor neurons (ORNs) and their support cells (sustentacular 
cells) and two types of potential stem cells; globose basal cells and horizontal basal cells. The LP contains extensions of ORN 
axons which are ensheathed by OECs. Supporting the glia and axons in the LP is loose connective tissue which contains fibrob-
lasts, Bowman glands and blood vessels. A-B) Calponin did not colocalise with an ORN marker (TUJ1 positive-red, calponin-
green and DAPI-blue). Figure 1B is a higher magnification of the boxed area in Figure 1A. Calponin did not colocalise with 
OECs as defined by expression of C) p75NTR (p75NTR -red, calponin-green, DAPI-blue) or D, E, F) S100 (S100-red, calponin-
green, DAPI-blue, * nerves). Figure 1F is a higher magnification of Figure 1E. All images were obtained using confocal micros-
copy.BMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
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SMA and calponin showed colabelling of both markers in
this same region (Figure 2A). α-SMA positive staining that
lacked calponin in this region was associated with blood
vessels. To remove the possibility that the calponin posi-
tive cells were OECs immunolabeled with α-SMA as has
been suggested by Jahed et al., [26] double immunofluo-
rescence for α-SMA and both S100 and p75NTR was per-
formed. No colocalisation was observed between α-SMA
and both OEC markers further supporting our evidence
for a lack of expression of calponin and α-SMA in neona-
tal OECs (Figure 2C, E, data not shown for S100). How-
ever, not all the cells immunoreactive for calponin
colabelled with α-SMA suggesting there was another cell
population that expressed calponin in the LP. Calponin
positive cells that lacked immunoreactivity to α-SMA were
seen in areas closer to the basal part of the OE (Figure 2A,
arrow). Double immunofluorescence for Fn and calponin
marked in general a different area of immunoreactivity
than  α-SMA in the LP (compare Figure 2A and 2B at
arrow). Fn colocalised with some calponin in the area
directly underneath the basal layer of the olfactory epithe-
lium (Figure 2B, arrow). This suggests that another con-
nective tissue cell co-expresses Fn and calponin but lacks
α-SMA (Figure 2F). A proportion of the Fn positive cells
which lacked calponin must be OECs as they coexpress
p75NTR (Figure 2D, arrow). Similar staining patterns were
obtained when proteinase K was either included or
excluded from the protocol (Figure 2G). Once more, con-
trol experiments in which the primary antibody was omit-
ted, were negative (Figure 2H).
Calponin is not expressed in the embryonic olfactory 
mucosa in vivo
Embryonic olfactory mucosa was immunostained in the
presence and absence of proteinase K with the same mark-
ers used in neonatal OM tissue to reveal possible age-
related calponin expression in OECs. Embryonic olfactory
neurons and their axons were imunoreactive for TUJ1
(Figure 3A). p75NTR positive OECs and Fn positive con-
nective tissue were detected in the LP as seen for neonatal
tissue (Figure 3A–C). No immunoreactivity for calponin
could be detected in any region of the embryonic olfactory
mucosa. Furthermore inclusion of proteinase K did not
reveal calponin staining. The lack of calponin in the
embryonic tissue suggests that this protein is expressed
later on in the development in the olfactory connective
tissue. Control experiments in which the primary anti-
body was omitted were negative (Figure 3D).
Connective tissue in the lamina propria of theolfactory system in vivo expresses calponin Figure 2
Connective tissue in the lamina propria of theolfactory system in vivo expresses calponin. Sections of olfactory 
mucosa were immunolabeled with antibodies to connective tissue and glia together with calponin and visualized using confocal 
microscopy. A, B) Calponin immunoreactivity was associated with markers of connective tissue fibroblast-like cells, Fn (red) 
and α-SMA (red). Dashed area represents the central part of the LP associated with α-SMA immunoreactivity and the arrow 
indicates the area adjacent to the basal part of the OE. C, D) To identify connective tissue, sections were immunolabeled with 
α-SMA and Fn together with p75NTR. OECs (p75NTR-green) did not express α-SMA. Figure 2E is a higher magnification Figure 
2C. F) Double immunofluorescence with both connective tissue markers Fn and α-SMA. The α-SMA positive cells, located 
mainly in the central part of the LP, do no colocalise with Fn, that is intensively expressed in the boundary between LP and OE. 
G) Similar staining patterns were obtained when proteinase K was excluded from the protocol. H) No tissue staining occurred 
in control sections when the primary antibody was excluded (DAPI, blue).BMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
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Calponin is not expressed by purified OECs and Schwann 
cells in vitro
In Figure 4A, B, purified cultured OECs and Schwann cells
were plated onto coverslips and labeled with calponin
together with p75NTR. Since it has been reported that cal-
ponin immunoreactivity in glia was maximized by pre-
treatment with proteinase K [11], we compared methods
in which pretreatment was omitted. In the presence and
absence of proteinase K pretreatment both OECs and
Schwann cells expressed weak, nuclear, background levels
of calponin immunoreactivity (Figure 4Ai, ii, Bi, ii, illus-
trates cells treated with proteinase K but similar results
occurred for cells not treated). However, when the pri-
mary antibody was omitted this staining was reduced but
could still be detected suggesting that this nuclear back-
ground staining is non-specific attachment of the second-
ary antibody (Figure 4Aiii, iv and 4Biii, iv). Also, note the
similar nuclear background staining (arrowhead) in the
fibroblasts which express strong fibrillar calponin immu-
noreactivity (Figure 4Ci–iii, arrow). These fibroblast-like
cells were devoid of p75NTR immunoreactivity.
Calponin is expressed by fibroblast-like cells purified from 
olfactory tissue and sciatic nerve
To confirm the connective tissue origins of the contami-
nating calponin positive fibroblast-like cells observed in
the OEC and Schwann cell cultures, cultures enriched for
non glial cells were generated from neonatal olfactory
bulb and sciatic nerve by incubating the cultures in
DMEM containing 10% FBS (Figure 5A–B). Cultured cells
exhibited a fibroblast-like morphology and expressed
strong immunoreactivity for calponin with a characteristic
fibrillar appearance. These fibroblast-like cultures were
heterogeneous for the expression of α-SMA and Thy1.1
that resembles the heterogeneity we observed in the LP of
the  in vivo olfactory mucosa (Figure 5B, D). Double
immunofluorescence revealed colocalisation of calponin
with α-SMA and surface fibronectin, supporting the non-
glial origin of the calponin immunoreactivity observed in
the purified OEC and Schwann cell cultures (Figure 5E, F).
Calponin expression in confrontation assays is associated 
with astrocytes
It has been suggested that cultures of OECs are contami-
nated with Schwann cells [11]. A major functional differ-
ence between OECs and Schwann cells can be seen in their
ability to interact with astrocytes, with OECs clearly min-
gling with astrocytes and Schwann cells and astrocytes
forming boundaries [18,20,21]. These differences are
believed to be due to a differential FGF/heparin sulphate
proteoglycan signaling cascade [21]. To illustrate the
purity of our OEC preparation, we set up these confronta-
tion assays and immunolabeled the cells with GFAP,
p75NTR and calponin. These assays take 10–14 days for the
cells to meet and are carried out in DMEM -10% FBS. As
Schwann cells take up Brdu in DMEM-10% FBS (data not
shown) we believe this would be enough time for any
possible contaminating Schwann cells to increase in
number. Therefore, we would expect any contaminating
Schwann cells in these confrontation assays to affect
boundary formation. Due to the similarity in the class spe-
cific secondary antibody for calponin and p75NTR, OECs
and Schwann cells in these cultures were detected by the
blue DAPI nuclei associated with unlabeled cells, and sis-
ter coverslips were immunolabeled with p75NTR  and
GFAP. In Figure 6A, C confrontation assays between
Schwann cells and OECs with astrocytes can be seen.
OECs mingled with astrocytes (Figure 6A) while the
Schwann cells formed a boundary (Figure 6C, arrows). To
our surprise, calponin staining could be seen to be associ-
ated with astrocytes and not OECs or Schwann cells (Fig-
ure 6B, D, asterisk). This difference in the way Schwann
cells interact with astrocytes in confrontation assays when
compared to OECs gives support to the view that there is
no Schwann cell contamination in OEC cultures after at
least 2 weeks.
To confirm cultured astrocytes express calponin, we gen-
erated two types of astrocytes, cortical astrocytes (CAs)
and astrocytes differentiated from neurospheres (NsAs).
Cortical astrocytes were over 98% pure as assessed by
Calponin is not expressed in embryonic tissue Figure 3
Calponin is not expressed in embryonic tissue. The 
olfactory mucosa was immunolabeled with antibodies to 
identify A) ORNs (TUJ1-red, Fn-green, DAPI-blue), B) con-
nective tissue (Fn-red, calponin-green, DAPI-blue), C) OECs 
(p75NTR-red, calponin-green, DAPI-blue) and D) control tis-
sue omitting the primary antibody. Images were obtained 
using the confocal microscope. The embryonic olfactory 
mucosa lacked any calponin immunoreactivity even though it 
expressed other markers which defined the OECs and con-
nective tissue seen in the P7 olfactory mucosa.BMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
Page 6 of 11
(page number not for citation purposes)
GFAP expression and these astrocytes express calponin
heterogeneously (Figure 6E–F). The calponin was fibrillar
and similar to that seen for fibroblasts. Astrocytes gener-
ated from P1 neurospheres by incubation in DMEM con-
taining 10% FBS also expressed fibrillar calponin in a
heterogeneous manner (Figure 6G). Control cultures
without primary antibody were negative although a weak
background staining was also detected as seen for OECs
and Schwann cells (Figure 6H).
Discussion
OECs and Schwann cells have been proposed as candi-
dates for transplant mediated repair strategies of spinal
cord injury. Previous studies have shown that they share a
number of remarkably similar phenotypes, and growth
factor responses [15,22,23,27]. It is only recently that
molecular studies have identified differences between
these two cell types specifically in their interaction with
astrocytes [17-19,21,28]. Furthermore, evidence suggests
that other cell types, eg. fibroblast-like cells, previously
rejected as contaminating cells, may have a role in
enhancing repair. Indeed, studies are coming to light that
suggest that the extracellular matrix produced by these
contaminating fibroblast-like cells may also have an
important role in mediating repair [29-31]. For this rea-
son it is quite important to identify the individual cells
used in transplant-mediate repair to assess their contribu-
tion to resulting regeneration. To date there has been no
markers identified that specifically labels OECs or distin-
guishes them from Schwann cells. Recently it has been
proposed that calponin is a specific marker which is able
to distinguish OECs from Schwann cells [11,24]. Using
this marker to immunolabel cultures of OECs, a mixture
of p75NTR positive/calponin positive and p75NTR positive/
Purified OECs and Schwann cells in vitro do not express calponin Figure 4
Purified OECs and Schwann cells in vitro do not express calponin. OECs and Schwann cells were immunolabeled with 
calponin in the presence and absence of proteinase K and no differences were found. A, B) OECs and Schwann cells were 
immuolabelled with p75NTR (red) and calponin (green). Greater than 99% of the cells immunolabeled with p75NTR (red) but a 
background level of green, punctate immunoreactivity could be seen associated with the nuclei (Ai, ii, Bi, ii, arrows). When pri-
mary antibody was omitted weaker punctate staining could just be detected (Aiii, iv, Biii, iv) Ci, ii) OEC and Schwann cell cul-
tures containing rare fibroblast contaminants (arrows) were immunolabeled with calponin (green) and p75NTR (red). It can be 
seen that the calponin immunoreactivity in the fibroblasts was strongly fibrillar and distinct from the non-specific attachment of 
the secondary antibody detected in OECs and Schwann cells. Ciii) illustrates a higher power image of contaminating fibroblasts 
which although expressed fibrillar calponin immunoreactivity, also expressed the punctate nuclear background immunoreactiv-
ity seen in OECs and Schwann cells. Images for Figures A, B and Ciii were obtained using a confocal microscope and images for 
Figures Ci, ii were obtained using a fluorescent microscope.BMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
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calponin negative cells were seen and it was proposed that
cells lacking calponin immunoreactivity was attributed to
contaminating Schwann cells. For this reason the authors
suggest that any myelination seen in vivo after OEC trans-
plantation was solely due to contaminating Schwann cells
[11]. This hypothesis has been challenged with evidence
demonstrating a lack of calponin staining in the adult rat
olfactory system [25]. In this report only adult tissue was
examined as it was suggested autologous transplantation
is likely to be the basis of clinical translation studies, but
an ongoing clinical trial in China is using embryonic
olfactory tissue as their source of tissue [32]. Furthermore,
it is necessary to examine calponin expression in neonatal
OECs and embryonic tissue to allow comparison with the
many cell transplantation studies in the literature that has
used neonatal OECs and with the original proteomic
analysis which used foetal OECs [24]. A study on neonatal
and embryonic tissue allows comparison to be made of
calponin expression during development and any possi-
ble age-related expression in OECs.
In our study we demonstrate that calponin immunoreac-
tivity may be detected in both OECs and Schwann cells in
culture although the expression is not typical of calponin
immunoreactivity reported in the literature. The calponin
immunoreactivity for the glial cells was punctate and
nuclear and not fibrillar as seen in muscle cells [33] or in
fibroblast as demonstrated in this study (Figure 5) and by
others [25]. However, omitting the primary antibody
reduced but did not remove this punctate staining around
the nucleus. On the other hand, we found similar nuclear,
punctate immunoreactivity in strongly positive fibroblasts
which suggests the punctate staining seen in Schwann
cells and OECs is more likely to be background non-spe-
cific staining. We initially hypothesized that the nuclear
staining detected in the OECs and Schwann cells may be
due to proteinase K treatments (recommended for tissue
immunocytochemistry by the antibody supplier) but we
had identical staining in the presence and absence of pro-
teinase K with methanol fixation. In support of this, all of
our immunohistochemistry of tissue sections was carried
out with proteinase K pretreatment, but still did not reveal
calponin staining in OECs. Thus, our data using neonatal
and embryonic tissue support the results from adult olfac-
tory tissue that calponin is not a marker for OECs [25].
Our in vivo studies identified strong calponin immunore-
activity in the connective tissue of the LP of neonatal rats.
Heterogeneous antigenic expression was detected in tissue
sections and purified cultured cells of the classical connec-
tive tissue markers, eg. antibodies to fibronectin, α-SMA,
[34-36] and Thy1.1 [37] (for fibroblasts and muscle cells),
together with the calponin antibody. Section of neonatal
mucosa showed regional differences in connective tissue
markers suggesting that subpopulations of fibroblasts
exist in the LP. The middle section of the LP contained α-
SMA immunoreactivity while the area adjacent to the OE
expressed mainly fibronectin and Thy1.1. A proportion of
this  α-SMA immunoreactivity could be attributed to
smooth muscle cells lining blood vessels but the distribu-
tion of α-SMA immunoreactivity was too large to be due
to these cells alone. In cell cultures prepared from the
olfactory bulb and sciatic nerve these markers identified
heterogeneously labeled fibroblast-like cells. This is con-
sistent with reports that α-SMA, calponin and Thy1.1
characterize subpopulations of fibroblasts [34,36,37].
Thus, our data suggest that connective tissue from the
olfactory mucosa is comprised of several subclasses of
fibroblasts. Although fibronectin labels connective tissue
we have seen coexpression with p75NTR  confirming
reports that OECs express fibronectin [38] and that
fibronectin expressed in the olfactory nerve layer of the
Fibroblast- like cells from the olfactory system and sciatic  nerve express calponin Figure 5
Fibroblast- like cells from the olfactory system and 
sciatic nerve express calponin. Neonatal olfactory bulb 
(A, B) and the sciatic nerve (C, D) were dissociated to obtain 
purified fibroblast-like cell cultures respectively. A, C) Puri-
fied fibroblast-like cultures from the olfactory bulb (A) and 
sciatic nerve (C) expressed calponin immunoreactivity 
(green) with typical fibrous appearance. B, D) Purified 
fibroblast-like cells immunolabeled for the connective tissue 
markers Thy1.1 (red) and α-SMA (green) in both olfactory 
bulb (B) and sciatic nerve (D). Colocalisation of both mark-
ers with calponin was shown for sciatic nerve fibroblasts. All 
images were obtained using a fluorescent microscope.BMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
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olfactory bulb is likely to be due to OECs [39]. However,
it has been suggested that neural crest precursor cells can
generate Schwann cells and endoneurial fibroblasts rais-
ing the possibility that this type of cell may exist in the
developing olfactory mucosa which transiently coexpress
p75NTR  and fibroblast markers [40]. Interestingly, the
expression of calponin in the connective tissue of neona-
tal LP may reflect developmental changes, since the olfac-
tory system of embryonic rats lacked calponin
immunoreactivity. This finding may have relevance for
CNS repair as mixed olfactory tissue is being proposed as
a more potent reparative cell mix for transplant-mediated
repair of spinal cord injury [29-31]. To be able to identify
and work with these different cells types may lead to a bet-
ter understanding of their role in CNS repair.
It has also been suggested that preparations of cultured
OECs are contaminated with Schwann cells [11]. OECs
used in this study are prepared from neonatal olfactory
bulbs using the O4 antibody and fluorescence activated
cell sorting [15] and are over 98% p75NTR pure. Although
we have seen lack of calponin staining in either of our
Schwann cells or OECs preparations, we believe that our
OEC preparations are devoid of Schwann cells due to their
inability to form any boundary in confrontation assays
[17,20]. To support this data we carried out confrontation
assays with OECs/astrocytes and Schwann cells/astrocytes
and immunolabeled the cells with calponin and GFAP.
Once more we saw the differential migratory behavior of
OECs and Schwann cells when in contact with astrocytes
and unexpectedly calponin immunoreactivity was associ-
Confrontation assays illustrate astrocytes express calponin Figure 6
Confrontation assays illustrate astrocytes express calponin. Confrontation assays were set up between OECs/astro-
cytes (A, B) and Schwann cells/astrocytes (C, D). A) OECs mingled with astrocytes while B) Schwann cells formed a boundary 
with astrocytes. Astrocytes expressed GFAP (red) and OECs or Schwann cells expressed p75NTR (green). B, D) When these 
cultures were labeled with calponin (green), GFAP (red) and DAPI for nuclei of the Schwann cells or OECs (blue) it could be 
seen that both OECs and Schwann cells lacked calponin expression (green immunoreactivity alone) but astrocytes expressed 
calponin (red and green immunoreactivity). E-G) Astrocytes generated from P1 cortex and P1 neurospheres were immunola-
beled with antibodies to GFAP (red) and to calponin (green). Neonatal cortical astrocytes (CAs) were over 98% pure as 
assessed by GFAP expression (E) and expressed fibrillar calponin heterogeneously (E-F). Astrocytes generated from neuro-
spheres (NsAs) by differentiation in DMEM- 10% FBS also expressed calponin heterogeneously in culture (G). H) No cell stain-
ing occurred in control cultures when the primary antibody was excluded (DAPI, blue). Images for Figures 6A-D, G were 
collected using the fluorescent microscope and images for Figures 6E, F, H were collected using confocal microscopy.BMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
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ated with astrocytes. Immunolabeling pure cultures of
astrocytes from two different sources supported the find-
ing that astrocytes express calponin. Other reports have
demonstrated calponin expression in the brain associated
with hippocampal and cerebellar neurons as well as radial
glia, Bergman glia, glia limitans and mature astrocytes
[41,42]. However these studies used an antibody to the
acidic isoform of calponin. Calponin is developmentally
expressed as 3 isoforms; α,β and γ. The basic α and β iso-
forms have molecular weights of 34 kD and 29 kD respec-
tively. An acidic isoform of calponin has also been
reported with a molecular weight of 36 kD [43]. It is this
acidic isoform that has been reported to be expressed in a
range of tissue and not just muscle cells [35,42]. The anti-
body we used in this study is the same antibody described
by Rizek and Kawaja [11] and the same clone (different
supplier) as described by Ibanez et al., [25] which recog-
nizes the basic calponin isoform. This suggests the basic
calponin isoform can be expressed by astrocytes in vitro.
Calponin expression in these astrocytes was heterogene-
ous and may reflect subsets of astrocytes or a differential
expression during the cell cycle [44,45].
Conclusion
Our data suggest that: i) calponin expression in the olfac-
tory mucosa was heterogeneous defining subpopulations
of connective tissue cells; ii) calponin did not label OECs
in embryonic and neonatal tissue; iii) neonatal OECs and
Schwann cells express weak, punctate, nuclear calponin
immunoreactivity in vitro, which correlates with a non-
specific staining also seen in astrocytes and fibroblasts; iv)
strong fibrillar basic calponin was expressed heterogene-
ously by astrocytes in vitro. These data demonstrate that
calponin is not a specific marker for rat OECs generated
from any developmental age.
Methods
Cell culture
Primary neural cells were purified and cultured as previ-
ously described. Neonatal OECs were purified from the
olfactory bulb of 7-day-old Sprague-Dawley rat pups
using the O4 antibody, anti-galactocerebroside and the
fluorescent activated cell sorter (FACSVantage Becton
Dickenson, [14]. OECs were cultured in defined medium
DMEM (DMEM-BS, [46]) with 5% FBS on poly-L-lysine
(PLL, 13 µg/ml; Sigma) coated 25 cm2 flasks, and further
supplemented with fibroblast growth factor 2 (FGF2, 500
ng/ml; Peprotech, London, UK), heregulin (hrgβ1, 50 ng/
ml; R&D Systems Europe Ltd., Abingdon, UK), forskolin
(10-6M; Sigma) and astrocyte conditioned medium
(ACM, [47]) which has been shown to be a potent
mitogen for promoting prolonged growth of p75 neuro-
trophin receptor (p75NTR) expressing OECs [48].
Schwann cells were obtained from sciatic nerves of 7-day-
old Sprague-Dawley rat pups and purified using a modifi-
cation of the method described by Brockes and colleagues
[49]. The modification involved an initial flick of the flask
after one day in culture to preferentially select for
Schwann cells, followed by incubation with Thy1.1 anti-
body (1:50 supernatant; Sigma, Dorst, UK) and rabbit
complement (1:6; Harlan Sera-lab Ltd, Loughborough,
UK) to reduce contamination by fibroblasts. Cells were
plated on PLL (13 µg/ml, Sigma) coated flasks and main-
tained in DMEM-10% FBS supplemented with forskolin
(10-6 M; Sigma) and hrgβ1, (20 ng/ml; R&D Systems
Europe Ltd, Oxon, UK).
Astrocytes were purified from the cortex as previously
described [18,47]. The cells were maintained in DMEM
containing 10% FBS on PLL coated flasks. ACM was col-
lected from confluent flasks of astrocytes by incubating
the cells in 10 mls of serum free DMEM [47] as described
in Lakatos et al., [18] for 48 hrs before collecting, spinning
and filtering [47]. Neurospheres were generated as
described by Reynolds and Weiss [50] from P1 striatum,
plated in neurobasal medium containing B27 supple-
ments (Invitrogen, Paisley, UK). Neurosphere astrocytes
were established by plating neurospheres onto PLL coated
coverslips and incubating them in DMEM containing
10% FBS for a week.
Immunocytochemistry
Cell purity was assessed by labeling the cells with GFAP
(glial fibrillary acid protein) antibody for astrocytes, and
p75NTR antibody for OECs and Schwann cells [51]. All cul-
tures were greater than 98% pure. The cells were main-
tained in culture at 37°C in 7% CO2 for no longer than 1
month and were refed twice a week. For immunofluores-
cence the cells were passaged onto PLL coated 13 mm cov-
erslips. To study cell surface antigen, cells were incubated
with the primary antibody for 30–40 min at room temper-
ature (RT) followed by the class specific antibody for 30
min at RT. Intracellular antibodies were incubated on cells
permeabilised using 100% ice cold methanol and placed
in the freezer for 15 min followed by their class specific
antibody as described above. Calponin staining was car-
ried out using the method and the same calponin anti-
body as described by Rizek and Kawaja [11]. Cells were
prefixed in 4% paraformaldehyde for 10 min followed by
incubation with the cell surface marker p75NTR and its
class specific fluorochrome-conjugated antibody as
described above. Cells were then fixed in 100% ice cold
methanol for 10 min followed by pretreatment with 20
µg/ml of proteinase K for 7 min and lastly incubated with
calponin for 1 hr and its class specific antibody for 30
min. Hank's solution (Gibco) containing 5% calf serum
and Hepes buffer was used to dilute the antibodies and for
washing between incubations. In some experiments pre-BMC Neuroscience 2007, 8:74 http://www.biomedcentral.com/1471-2202/8/74
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incubation with proteinase K was omitted. Primary anti-
bodies include monoclonal mouse anti-human Calponin
(1:50; IgG1, Dako, Ely, UK). To identify OECs we used
monoclonal mouse anti- and polyclonal rabbit anti-
p75NTR (hybridoma, 1:1; IgG1, [51], anti-rabbit, 1:800;
Abcam, Cambridge, UK) respectively; and rabbit polyclo-
nal anti-S100β [52] (1: 200; Dako). For identifying ORNs
we used monoclonal mouse anti-βIII tubulin (TUJ1,
1:100; IgG1, Sigma). Connective tissue was identified by
polyclonal rabbit anti-human fibronectin (1:100, Dako);
mouse monoclonal anti-alpha smooth muscle actin (α-
SMA, 1:400; IgG1, Chemicon, Hampshire, UK; [35] and
mouse monoclonal Thy1.1/CD90 (1:100; IgG1, Serotec).
Visualization of the primary antibodies was carried out
using the class specific antibodies conjugated with fluo-
rescein (green, FITC) or rhodamine (red, TRITC) (South-
ern Biotechnique, 1:100). Coverslips were mounted with
VectorShield (Vector laboratories, Peterborough, UK)
containing 4'6-diamidine-2-phenylindole-dihydrochlo-
ride (DAPI) to visualize the nuclei. Images were examined
either by confocal microscopy (Olympus FV-1000) or by
fluorescence microscopy (Zeiss Axioskop) using Meta-
Morph image analysis from Molecular Devices.
Tissue preparation and immunohistochemistry
The olfactory mucosa and olfactory bulbs were dissected
from the heads of postnatal day 7 Sprague-Dawley rat
pups. The tissue from the P7 rats and the heads from
embryonic E17-E20 pups were immersed in 4% parafor-
maldehyde for 1–3 days and then cryopreserved in 30%
sucrose solution until equilibration. Sections of 10–20
µm were cut using a Bright cryostat onto Vectabond (Vec-
tor Lab) coated slides. For immunohistochemistry, the
slides were washed 3 times for 5 min in PBS then treated
with proteinase K 20 µg/ml for 7 min, washed and incu-
bated in a blocking solution containing 10% goat serum
and 0.3% triton-X 100 (Sigma) in PBS for 1 hr at RT. Sec-
tions were then incubated in the primary antibodies
described above diluted in PBS-4%BSA for 2 hr at RT.
After 3 washes of 5 min with PBS the sections were incu-
bated with the appropriate FITC/TRITC conjugated anti-
mouse or anti-rabbit secondary 1:100 (Southern Biotech-
nique, Cambridge Bioscience, Cambridge, UK) for 1 hr.
After the incubation the sections were washed 3 times for
5 min with PBS and then mounted with VectorShield con-
taining DAPI.
Confrontation assays
Confrontation assays between OECs and astrocytes and
Schwann cells and astrocytes were set up as previously
described [17,18]. Briefly, 10-µl strips containing 10,000
cells of either OECs or Schwann cells were set up opposing
a parallel 10-µl strip containing 10,000 astrocytes on a
PLL-coated coverslip. Cells were allowed to attach for 1 hr
before washing in DMEM-FBS to remove non-attached
cells. Cultures were then maintained in DMEM-FBS, and
allowed to grow towards each other over a period of 10
days, giving time for cells to make contact and interact.
Cultures were then immunolabeled using antibodies to
GFAP and p75NTR or GFAP and calponin and mounted
with VectorShield containing DAPI to visualize nuclei.
Images were examined using fluorescence microscopy
(Zeiss Axioskop) using MetaMorph image analysis from
Molecular Devices. Because we can induce i) OECs to
form boundaries with astrocytes or ii) Schwann cells to
mingle with astrocytes by modifying the FGF/heparin sul-
phate proteoglycan signaling cascade; it is unlikely that
the different, initial, long-term culture conditions for
OECs and Schwann cells mediate the differential behavior
in the confrontation assays [21]. Furthermore, similar dif-
ferences in the way OECs and Schwann cells form bound-
aries with astrocytes have been demonstrated in vivo [21].
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